A novel synonymous mutation in the MPZ gene causing an aberrant splicing pattern and Charcot-Marie-Tooth disease type 1b

Shy, 2004, Phenotypic clustering in MPZ mutations, Brain, 127, 371, 10.1093/brain/awh048 Grandis, 2008, Different cellular and molecular mechanisms for early and late-onset myelin protein zero mutations, Hum Mol Genet, 17, 1877, 10.1093/hmg/ddn083 Richards, 2015, ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology, Genet Med, 17, 405, 10.1038/gim.2015.30 Besançon, 1999, Alternative exon 3 splicing of the human major protein zero gene in white blood cells and peripheral nerve tissue, FEBS Lett, 457, 339, 10.1016/S0014-5793(99)01069-8 Crehalet, 2010, U1 snRNAmis-binding: a new cause of CMT1B, Neurogenetics, 11, 13, 10.1007/s10048-009-0199-8 Taioli, 2011, Déjerine-Sottas syndrome with a silent nucleotide change of myelin protein zero gene, J Peripher Nerv Syst, 16, 59, 10.1111/j.1529-8027.2011.00319.x Sabet, 2006, Skin biopsies demonstrate MPZ splicing abnormalities in charcot-marie-tooth neuropathy 1B, Neurology, 67, 1141, 10.1212/01.wnl.0000238499.37764.b1 Khajavi, 2005, Curcumin treatment abrogates endoplasmic reticulum retention and aggregation-induced apoptosis associated with neuropathy-causing myelin protein zero–truncating mutants, Am J Hum Genet, 77, 841, 10.1086/497541 Szabo, 2005, Marked phenotypic variation in a family with a new myelin protein zero mutation, Neuromuscul Disord, 15, 760, 10.1016/j.nmd.2005.07.006